what happens if you take more semaglutide than prescribed Dosing Semaglutide for Weight Loss: How

Over the past five years, the global weight-loss drug market has evolved from GLP-1 single-target to dual-target therapies, driving peptides from early research into large-scale commercial development

Clinical trials primarily documented gastrointestinal side effects such as nausea, vomiting, and diarrhoea

Semaglutide is the active ingredient in the brand-name medications Ozempic, Wegovy, and Rybelsus

More About Semaglutide

Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025